ArticleJournal of cancer research and clinical oncology2023

New inflammatory indicators for cell-based liquid biopsy: association of the circulating CD44+/CD24- non-hematopoietic rare cell phenotype with breast cancer residual disease.

Stefan Schreier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.